LEXINGTON, Massachusetts, June 10, 2014 /PRNewswire/ --
Shire's Chief Executive Officer, Flemming Ornskov, MD will participate at the Goldman Sachs 35th Annual Global Healthcare Conference on Thursday, June 12th at 10:00 am PT/18:00 BST. Investors may access a live audio webcast of the presentation at http://www.shire.com/shireplc/en/investors.
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
For further information please contact:
Jeff Poulton, email@example.com, +1-781-482-0945
Sarah Elton-Farr, firstname.lastname@example.org, +44-1256-894157
SOURCE Shire plc